Cinnamomum verum component 2-methoxycinnamaldehyde: a novel antiproliferative drug inducing cell death through targeting both topoisomerase I and II in human colorectal adenocarcinoma COLO 205 cells

References

• Tanzer M, Liebl M, Quante M. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma. Pharmacol Ther. 2013; 140: 133–47. [PubMed Abstract].
   Google Scholar
• Yazdi MH, Faramarzi MA, Nikfar S, Abdollahi M. A comprehensive review of clinical trials on EGFR inhibitors such as cetuximab and panitumumab as,monotherapy and in combination for treatment of metastatic colorectal cancer. Avicenna J Med Biotechnol. 2015; 7: 134–44. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Sanoff HK, Sargent DJ, Campbell ME, Morton RF, Fuchs CS, Ramanathan RK, etal. Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J Clin Oncol. 2008; 26: 5721–7. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Hwa JS, Jin YC, Lee YS, Ko YS, Kim YM, Shi LY, etal. 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction. J Ethnopharmacol. 2012; 139: 605–15. [PubMed Abstract].
   Google Scholar
• Duke JA, Duke P-AK, duCellier JL. Duke's handbook of medicinal plants of the Bible. 2008; Boca Raton, FL: CRC Press.
   Google Scholar
• Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis. 2010; 31: 9–18. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Aleo E, Henderson CJ, Fontanini A, Solazzo B, Brancolini C. Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis. Cancer Res. 2006; 66: 9235–44. [PubMed Abstract].
   Google Scholar
• McClendon AK, Osheroff N. DNA topoisomerase II, genotoxicity, and cancer. Mutat Res. 2007; 623: 83–97. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Heck MM, Earnshaw WC. Topoisomerase II: a specific marker for cell proliferation. J Cell Biol. 1986; 103: 2569–81. [PubMed Abstract].
   Google Scholar
• Naowaratwattana W, De-Eknamkul W, De Mejia EG. Phenolic-containing organic extracts of mulberry (Morus alba L.) leaves inhibit HepG2 hepatoma cells through G2/M phase arrest, induction of apoptosis, and inhibition of topoisomerase IIalpha activity. J Med Food. 2010; 13: 1045–56. [PubMed Abstract].
   Google Scholar
• Baikar S, Malpathak N. Secondary metabolites as DNA topoisomerase inhibitors: a new era towards designing of anticancer drugs. Pharmacogn Rev. 2010; 4: 12–26. [PubMed Abstract].
   Google Scholar
• Bandele OJ, Clawson SJ, Osheroff N. Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement. Chem Res Toxicol. 2008; 21: 1253–60. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Sudan S, Rupasinghe HP. Flavonoid-enriched apple fraction AF4 induces cell cycle arrest, DNA topoisomerase II inhibition, and apoptosis in human liver cancer HepG2 cells. Nutr Cancer. 2014; 66: 1237–46. [PubMed Abstract].
   Google Scholar
• Fan C, Wang W, Zhao B, Zhang S, Miao J. Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells. Bioorg Med Chem. 2006; 14: 3218–22. [PubMed Abstract].
   Google Scholar
• Olive PL, Banath JP. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc. 2006; 1: 23–9. [PubMed Abstract].
   Google Scholar
• Ono K, Wang X, Han J. Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency. Mol Cell Biol. 2001; 21: 8276–88. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Reers M, Smiley ST, Mottola-Hartshorn C, Chen A, Lin M, Chen LB. Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol. 1995; 260: 406–17. [PubMed Abstract].
   Google Scholar
• Martin EJ, Forkert PG. Evidence that 1, 1-dichloroethylene induces apoptotic cell death in murine liver. J Pharmacol Exp Ther. 2004; 310: 33–42. [PubMed Abstract].
   Google Scholar
• Har-Vardi I, Mali R, Breietman M, Sonin Y, Albotiano S, Levitas E, etal. DNA topoisomerases I and II in human mature sperm cells: characterization and unique properties. Hum Reprod. 2007; 22: 2183–9. [PubMed Abstract].
   Google Scholar
• Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980; 68: 251–306. [PubMed Abstract].
   Google Scholar
• Cover TL, Puryear W, Perez-Perez GI, Blaser MJ. Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun. 1991; 59: 1264–70. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Patel HK, Willhite DC, Patel RM, Ye D, Williams CL, Torres EM, etal. Plasma membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin. Infect Immun. 2002; 70: 4112–23. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Pommier Y. Diversity of DNA topoisomerases I and inhibitors. Biochimie. 1998; 80: 255–70. [PubMed Abstract].
   Google Scholar
• Li TK, Liu LF. Tumor cell death induced by topoisomerase-targeting drugs. Annu Rev Pharmacol Toxicol. 2001; 41: 53–77. [PubMed Abstract].
   Google Scholar
• Lev-Ari S, Starr A, Vexler A, Karaush V, Loew V, Greif J, etal. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res. 2006; 26: 4423–30. [PubMed Abstract].
   Google Scholar
• Oxnard GR, Binder A, Janne PA. New targetable oncogenes in non-small-cell lung cancer. J Clin Oncol. 2013; 31: 1097–104. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Fujiki H, Suganuma M, Kurusu M, Okabe S, Imayoshi Y, Taniguchi S, etal. New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen. Mutat Res. 2003; 523–4: 119–25.
   Web of Science ®Google Scholar
• Yang CS, Wang H, Li GX, Yang Z, Guan F, Jin H. Cancer prevention by tea: evidence from laboratory studies. Pharmacol Res. 2011; 64: 113–22. [PubMed Abstract].
   Google Scholar
• Packer L, Wachtel-Galor S, Ong CN, Halliwell B. Herbal and traditional medicine: biomolecular and clinical aspects. 2004; Boca Raton, FL: CRC Press.
   Google Scholar
• Izzo AA, Capasso F. Herbal medicine, cancer prevention and cyclooxygenase 2 inhibition. Trends Pharmacol Sci. 2003; 24: 218–19. [PubMed Abstract].
   Google Scholar
• Trudel D, Labbe DP, Bairati I, Fradet V, Bazinet L, Tetu B. Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies. Gynecol Oncol. 2012; 126: 491–8. [PubMed Abstract].
   Google Scholar
• Fujiki H, Sueoka E, Watanabe T, Suganuma M. Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds. J Cancer Prev. 2015; 20: 1–4. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Wang CZ, Anderson S, Du W, He TC, Yuan CS. Red ginseng and cancer treatment. Chin J Nat Med. 2016; 14: 7–16. [PubMed Abstract].
   Google Scholar
• Hosseinzadehdehkordi M, Adelinik A, Tashakor A. Dual effect of curcumin targets reactive oxygen species, adenosine triphosphate contents and intermediate steps of mitochondria-mediated apoptosis in lung cancer cell lines. Eur J Pharmacol. 2015; 769: 203–10. [PubMed Abstract].
   Google Scholar
• Nicastro HL, Ross SA, Milner JA. Garlic and onions: their cancer prevention properties. Cancer Prev Res (Phila). 2015; 8: 181–9. [PubMed Abstract].
   Google Scholar
• Zhang Z, Wang Y, Yao R, Li J, Yan Y, La Regina M, etal. Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models. Oncogene. 2004; 23: 3841–50. [PubMed Abstract].
   Google Scholar
• Yuan JM, Sun C, Butler LM. Tea and cancer prevention: epidemiological studies. Pharmacol Res. 2011; 64: 123–35. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ye L, Jia Y, Ji KE, Sanders AJ, Xue K, Ji J, etal. Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis. Oncol Lett. 2015; 10: 1240–50. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Tanaka S, Yoon YH, Fukui H, Tabata M, Akira T, Okano K, etal. Antiulcerogenic compounds isolated from Chinese cinnamon. Planta Med. 1989; 55: 245–8. [PubMed Abstract].
   Google Scholar
• Reddy AM, Seo JH, Ryu SY, Kim YS, Kim YS, Min KR, etal. Cinnamaldehyde and 2-methoxycinnamaldehyde as NF-kappaB inhibitors from Cinnamomum cassia. Planta Med. 2004; 70: 823–7. [PubMed Abstract].
   Google Scholar
• Shukla S, Meeran SM, Katiyar SK. Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention. Cancer Lett. 2014; 355: 9–17. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Priyadarsini RV, Nagini S. Cancer chemoprevention by dietary phytochemicals: promises and pitfalls. Curr Pharm Biotechnol. 2012; 13: 125–36. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003; 3: 768–80. [PubMed Abstract].
   Google Scholar
• Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr. 2001; 21: 381–406. [PubMed Abstract].
   Google Scholar
• Watson WH, Cai J, Jones DP. Diet and apoptosis. Annu Rev Nutr. 2000; 20: 485–505. [PubMed Abstract].
   Google Scholar
• Middleton E Jr., Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000; 52: 673–751. [PubMed Abstract].
   Google Scholar
• Miura T, Chiba M, Kasai K, Nozaka H, Nakamura T, Shoji T, etal. Apple procyanidins induce tumor cell apoptosis through mitochondrial pathway activation of caspase-3. Carcinogenesis. 2008; 29: 585–93. [PubMed Abstract].
   Google Scholar
• Liu JR, Dong HW, Chen BQ, Zhao P, Liu RH. Fresh apples suppress mammary carcinogenesis and proliferative activity and induce apoptosis in mammary tumors of the Sprague-Dawley rat. J Agric Food Chem. 2009; 57: 297–304. [PubMed Abstract].
   Google Scholar
• Yoon H, Liu RH. Effect of selected phytochemicals and apple extracts on NF-kappaB activation in human breast cancer MCF-7 cells. J Agric Food Chem. 2007; 55: 3167–73. [PubMed Abstract].
   Google Scholar
• Zheng CQ, Qiao B, Wang M, Tao Q. Mechanisms of apple polyphenols-induced proliferation inhibiting and apoptosis in a metastatic oral adenoid cystic carcinoma cell line. Kaohsiung J Med Sci. 2013; 29: 239–45. [PubMed Abstract].
   Google Scholar
• Pop C, Timmer J, Sperandio S, Salvesen GS. The apoptosome activates caspase-9 by dimerization. Mol Cell. 2006; 22: 269–75. [PubMed Abstract].
   Google Scholar
• Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 1997; 90: 405–13. [PubMed Abstract].
   Google Scholar
• Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, etal. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997; 91: 479–89. [PubMed Abstract].
   Google Scholar
• Husain I, Mohler JL, Seigler HF, Besterman JM. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res. 1994; 54: 539–46. [PubMed Abstract].
   Google Scholar
• Hsiang YH, Wu HY, Liu LF. Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Res. 1988; 48: 3230–5. [PubMed Abstract].
   Google Scholar
• Baldwin EL, Osheroff N. Etoposide, topoisomerase II and cancer. Curr Med Chem Anticancer Agents. 2005; 5: 363–72. [PubMed Abstract].
   Google Scholar
• El-Awady RA, Ali MM, Saleh EM, Ghaleb FM. Apoptosis is the most efficient death-pathway in tumor cells after topoisomerase II inhibition. Saudi Med J. 2008; 29: 558–64. [PubMed Abstract].
   Google Scholar
• Denny WA, Baguley BC. Dual topoisomerase I/II inhibitors in cancer therapy. Curr Top Med Chem. 2003; 3: 339–53. [PubMed Abstract].
   Google Scholar